Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 105,659 | 71,962 | 69,157 | 67,689 | 62,273 |
| Operating Income | -105,659 | -71,962 | -69,157 | -67,689 | -62,273 |
| Other Income | 8,534 | 6,860 | 3,508 | 1,051 | 2,063 |
| Pre-tax Income | -97,125 | -65,102 | -65,649 | -66,638 | -60,210 |
| Net Income Continuous | -97,125 | -65,102 | -65,649 | -66,638 | -60,210 |
| Net Income | $-97,125 | $-65,102 | $-65,649 | $-66,638 | $-60,210 |
| EPS Basic Total Ops | -0.96 | -0.70 | -0.81 | -1.10 | -0.99 |
| EPS Basic Continuous Ops | -0.96 | -0.70 | -0.81 | -1.10 | -0.99 |
| EPS Diluted Total Ops | -0.96 | -0.70 | -0.81 | -1.10 | -0.99 |
| EPS Diluted Continuous Ops | -0.96 | -0.70 | -0.81 | -1.10 | -0.99 |
| EPS Diluted Before Non-Recurring Items | -0.96 | -0.70 | -0.81 | -1.09 | N/A |
| EBITDA(a) | $-106,197 | $-72,832 | $-69,294 | $-67,484 | $-62,207 |